Publications by authors named "Brian Belt"

Claim this Profile
I
Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma.
Joseph D Murphy, Gary Hannon, Bradley N Mills, Angela L Hughson, Taylor P Uccello, Brian A Belt

Int J Radiat Oncol Biol Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models.
Jian Ye, Shuyang S Qin, Angela L Hughson, Gary Hannon, Noah A Salama, Brian A Belt

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models.
Jian Ye, Shuyang S Qin, Angela L Hughson, Gary Hannon, Tara G Vrooman, Brian A Belt

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival for Liver Transplant vs Alternative Therapy in Unresectable Colorectal Liver Metastasis.
Matthew M Byrne, Mariana Chávez-Villa, Luis I Ruffolo, Kerollos Nashat Wanis, Brian Belt

JAMA Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
Paul R Burchard, Luis I Ruffolo, Nicholas A Ullman, Benjamin S Dale, Yatee A Dave, Brian A Belt

Hepatol Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smad4 restricts injury-provoked biliary proliferation and carcinogenesis.
William B Alexander, Wenjia Wang, Margaret A Hill, Michael R O'Dell, Luis I Ruffolo, Brian A Belt

Dis Model Mech· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes.
Xianlu Laura Peng, Elena V Kharitonova, Yi Xu, Joseph F Kearney, Changfei Luan, Brian A Belt

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models.
Jian Ye, Nicholas W Gavras, David C Keeley, Angela L Hughson, Gary Hannon, Brian A Belt

J Immunother Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferior Survival Is Associated With Socioeconomic Deprivation in Hepatocellular Carcinoma.
Luis I Ruffolo, Dennis Zambrano, Benjamin S Dale, Sai V Nimmagadda, Madelaine Hack, Brian A Belt

J Surg Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.
Luis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, Benjamin S Dale, Nathania M Figueroa Guilliani, Brian A Belt

Gut· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
Jian Ye, Bradley N Mills, Shuyang S Qin, Jesse Garrett-Larsen, Joseph D Murphy, Brian A Belt

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy.
Bradley N Mills, Haoming Qiu, Michael G Drage, Chunmo Chen, Jocelyn S Mathew, Brian A Belt

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Picomets: Assessing single and few cell metastases in melanoma sentinel lymph node biopsies.
Katherine Jackson, Luis Ruffolo, Lauren Kozakiewicz, Shuyang S Qin, Alexander C Chacon, Brian Belt

Surgery· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma.
Booyeon J Han, Joseph D Murphy, Shuyang Qin, Jian Ye, Taylor P Uccello, Brian A Belt

Immunol Invest· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Marcus Noel, Eileen M O'Reilly, Brian M Wolpin, David P Ryan, Andrea J Bullock, Brian A Belt

Invest New Drugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer.
Jian Ye, Bradley N Mills, Tony Zhao, Booyeon J Han, Joseph D Murphy, Brian A Belt

Cancer Immunol Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer.
Naim U Rashid, Xianlu L Peng, Chong Jin, Richard A Moffitt, Keith E Volmar, Brian A Belt

Clin Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.
Bradley N Mills, Kelli A Connolly, Jian Ye, Joseph D Murphy, Taylor P Uccello, Brian A Belt

Cell Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of CCR2 tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer.
Julie G Grossman, Timothy M Nywening, Brian A Belt, Roheena Z Panni, Bradley A Krasnick

Oncoimmunology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting both tumour-associated CXCR2 neutrophils and CCR2 macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
Timothy M Nywening, Brian A Belt, Darren R Cullinan, Roheena Z Panni, Booyeon J Han

Gut· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes.
Kelli A Connolly, Brian A Belt, Nathania M Figueroa, Aditi Murthy, Ankit Patel

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis.
Megan K Ruhland, Andrew J Loza, Aude-Helene Capietto, Xianmin Luo, Brett L Knolhoff, Brian A Belt

Nat Commun· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, Brian A Belt, Roheena Z Panni

Lancet Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membrane.
Yang Su, Katharina Tatzel, Xuejun Wang, Brian Belt, Pratibha Binder

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.
Roheena Z Panni, Dominic E Sanford, Brian A Belt, Jonathan B Mitchem, Lori A Worley

Cancer Immunol Immunother· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis